Cervical and other anogenital cancers are initiated by infection with one of a small group of
human papillomaviruses (HPV). Virus-like particle-based vaccines have recently been …

HPV-16 is the major causes of cervical cancer. Persistence of infection is a necessary event
for progression of the infection to cancer. Among other factors, virus persistence is due the …

Long-term remission in acute myeloid leukemia (AML) is generally not durable only being
achieved in o50% of patients. 1 Consequently there is a need to establish new treatments to …

Human papillomavirus type 16 (HPV-16) is the most prevalent virus in human cervical
cancers, as it is present in more than half of all cases. Many studies have found continued …

The most common high‐risk human papillomavirus types, HPV16 and 18, differ markedly
with respect to their interaction with the host. Clearance of HPV18 infections generally takes …

Human papillomavirus types 16 and 18 cause the majority of cervical cancers worldwide.
Despite the availability of three prophylactic vaccines based on virus-like particles (VLP) of …

Human papillomavirus (HPV) infection with low-risk or high-risk subtypes is very common.
Infection with HPVs is often a major causative factor for the development of cutaneous …

The human CD8+ T cell clone 6C5 has previously been shown to recognize the tert-butyl-
modified Bax 161–170 peptide LLSY (3-tBu) FGTPT presented by HLA-A* 02: 01. This …

Potent professional antigen-presenting cells (APC) are essential tools to activate and
expand antigen-specific T cells in vitro for use in adoptive immunotherapy. CD40-activated B …

Cancer cells frequently exhibit defects in apoptosis, which contribute to increased survival
and chemotherapeutic resistance. For example, genetic mutations or abnormal proteasomal …